Gene-Linked Iron Disorder More Common Than Thought
Gene-Linked Iron Disorder More Common Than Thought

Gene-Linked Iron Disorder More Common Than Thought

The most common genetic disorder among northern Europeans -- called hemochromatosis—occurs more often than previously thought.

HealthDay News


WEDNESDAY, Jan. 16, 2019 (HealthDay News) -- The most common genetic disorder among northern Europeans -- called hemochromatosis -- occurs more often than previously thought, according to a new study.

READ: 9 Low Iron Symptoms

The researchers also found that people with the condition often develop serious health problems.

People with hemochromatosis -- a build-up of iron in the body that can damage the liver, heart and other organs -- have two copies of a faulty gene called HFE C282Y. Treatment with regular removal of iron-rich blood is safe and effective if started early, but symptoms such as extreme tiredness and joint pain are often mistaken for normal signs of aging.

In the new study, researchers analyzed data from nearly 2,900 people with HFE C282Y mutations in the United Kingdom. The study participants, aged 40 to 70, were part of a database of more than 500,000 men and women recruited between 2006 and 2010.

The participants were followed for an average of seven years. After accounting for age and other genetic factors, the researchers found that hemochromatosis was diagnosed in nearly 22 percent of men and 10 percent of women.

Those rates were much higher than previous estimates, the study authors said.

Compared to people without the mutations, one in five more men and one in 10 more women with the faulty gene had developed liver disease, diabetes, osteoarthritis or rheumatoid arthritis by the end of the study period.

Among those with the mutations, more disease developed at older ages and they had a higher risk of premature death, including from liver cancer, according to the team led by David Melzer of the University of Exeter, in England.

The study was published Jan. 16 in the BMJ.

Previous studies have suggested that few people with HFE C282Y mutations develop hemochromatosis, and health problems among them are rare.

These new findings suggest the need for screening and better early detection of these gene mutations, the study authors concluded in a journal news release.

SOURCE: BMJ, news release, Jan. 16, 2019

Copyright © 2019 HealthDay. All rights reserved.

ADVERTISEMENT

How Inequity Gets Built Into America’s Vaccination System

People eligible for the coronavirus vaccine are running up against barriers that are designed into the very systems meant to serve those most at risk of dying of the disease.

Prevention & Screenings

Vape Sellers Are Using Popular Music Videos to Promote E-Cigarettes to Young People – and It’s Working

Teens and young adults spend several hours a day looking at their phones and watching videos, many of which might contain product placements for vaping.

Your Health

How to Get Prior Authorization for Your Patients

92% of doctors report that prior authorizations cause delays in patient care

Created With Support